Clinical Trial Update: Relationship Between Pharmacokinetics and Safety of Vismodegib - OPTIVISMO-1 [Phase 4]

View source ↗

Summary

Phase 4 trial update examining how pharmacokinetics relate to safety signals for vismodegib in basal cell carcinoma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Vismodegib (Vismodegib)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Metastatic Basal Cell Carcinoma, Locally Advanced Basal Cell Carcinoma | Phase 4 | Status: COMPLETED